Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
Nicholas Taylor(Segeberger Kliniken), Jonathan S. Serody(University of North Carolina at Chapel Hill), Sarah C. Vick(Fred Hutch Cancer Center), Benjamin G. Vincent(University of North Carolina at Chapel Hill), W. June Brickey(University of North Carolina at Chapel Hill), Shannon Reisdorf(Segeberger Kliniken), Lisa A. Carey(University of North Carolina at Chapel Hill), Joel S. Parker(University of North Carolina at Chapel Hill), Charles M. Perou(University of North Carolina at Chapel Hill), Michael D. Iglesia(Washington University in St. Louis), Karen P. McKinnon(Segeberger Kliniken), Bentley R. Midkiff(Segeberger Kliniken), Carey K. Anders(Duke University)
Cited by 143
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k